Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011.

<h4>Objectives</h4>This study was intended to explore the etiology and risk factors of severe neonatal hyperbilirubinemia and to analyze the adverse events associated with ECT (Exchange Transfusion), as well as to identify the factors related to the poor prognosis.<h4>Methods</h...

Full description

Saved in:
Bibliographic Details
Main Authors: Canfeng Yu, Huifan Li, Qiannan Zhang, Huayun He, Xinhong Chen, Ziyu Hua
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179550&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849766164260978688
author Canfeng Yu
Huifan Li
Qiannan Zhang
Huayun He
Xinhong Chen
Ziyu Hua
author_facet Canfeng Yu
Huifan Li
Qiannan Zhang
Huayun He
Xinhong Chen
Ziyu Hua
author_sort Canfeng Yu
collection DOAJ
description <h4>Objectives</h4>This study was intended to explore the etiology and risk factors of severe neonatal hyperbilirubinemia and to analyze the adverse events associated with ECT (Exchange Transfusion), as well as to identify the factors related to the poor prognosis.<h4>Methods</h4>All of the full-term neonates who had undergone ECT for hyperbilirubinemia at Children's Hospital of Chongqing Medical University from January 2001 to December 2011 were enrolled in this study. General demographic characteristics, comorbidities, pre- and post-exchange TSB(Total Serum Bilirubin) levels, duration and frequency of ECT, and clinical outcomes were recorded and analyzed anonymously.<h4>Results</h4>Of 614 total infants, 368 patients (59.9%) with ABO incompatibility were identified, of whom 197 (53.5%) developed acute bilirubin encephalopathy (ABE) and 16 (4.3%) suffered a poor prognosis. The etiology was unidentified in 103 patients (16.8%), of whom 62 (60.1%) developed ABE and 9 (8.7%) had a poor prognosis. Identified adverse events secondary to ECT included thrombocytopenia (54.6%), hyperglycemia (42.8%), apnea (3.3%) and necrotizing enterocolitis (NEC) (1.3%). No ECT-related mortality was documented in this study.<h4>Conclusions</h4>The etiology, peak TSB level before ECT, and time of ECT had a significant impact on the outcome of severe neonatal hyperbilirubinemia. ABO incompatibility was the most common cause of extreme neonatal hyperbilirubinemia. Pathological weight loss could be involved in the development of extreme hyperbilirubinemia with an unidentified cause.
format Article
id doaj-art-249543baeb0444919c27bec34fcd1809
institution DOAJ
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-249543baeb0444919c27bec34fcd18092025-08-20T03:04:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017955010.1371/journal.pone.0179550Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011.Canfeng YuHuifan LiQiannan ZhangHuayun HeXinhong ChenZiyu Hua<h4>Objectives</h4>This study was intended to explore the etiology and risk factors of severe neonatal hyperbilirubinemia and to analyze the adverse events associated with ECT (Exchange Transfusion), as well as to identify the factors related to the poor prognosis.<h4>Methods</h4>All of the full-term neonates who had undergone ECT for hyperbilirubinemia at Children's Hospital of Chongqing Medical University from January 2001 to December 2011 were enrolled in this study. General demographic characteristics, comorbidities, pre- and post-exchange TSB(Total Serum Bilirubin) levels, duration and frequency of ECT, and clinical outcomes were recorded and analyzed anonymously.<h4>Results</h4>Of 614 total infants, 368 patients (59.9%) with ABO incompatibility were identified, of whom 197 (53.5%) developed acute bilirubin encephalopathy (ABE) and 16 (4.3%) suffered a poor prognosis. The etiology was unidentified in 103 patients (16.8%), of whom 62 (60.1%) developed ABE and 9 (8.7%) had a poor prognosis. Identified adverse events secondary to ECT included thrombocytopenia (54.6%), hyperglycemia (42.8%), apnea (3.3%) and necrotizing enterocolitis (NEC) (1.3%). No ECT-related mortality was documented in this study.<h4>Conclusions</h4>The etiology, peak TSB level before ECT, and time of ECT had a significant impact on the outcome of severe neonatal hyperbilirubinemia. ABO incompatibility was the most common cause of extreme neonatal hyperbilirubinemia. Pathological weight loss could be involved in the development of extreme hyperbilirubinemia with an unidentified cause.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179550&type=printable
spellingShingle Canfeng Yu
Huifan Li
Qiannan Zhang
Huayun He
Xinhong Chen
Ziyu Hua
Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011.
PLoS ONE
title Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011.
title_full Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011.
title_fullStr Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011.
title_full_unstemmed Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011.
title_short Report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in Southwestern China during an 11-year period, from 2001 to 2011.
title_sort report about term infants with severe hyperbilirubinemia undergoing exchange transfusion in southwestern china during an 11 year period from 2001 to 2011
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179550&type=printable
work_keys_str_mv AT canfengyu reportaboutterminfantswithseverehyperbilirubinemiaundergoingexchangetransfusioninsouthwesternchinaduringan11yearperiodfrom2001to2011
AT huifanli reportaboutterminfantswithseverehyperbilirubinemiaundergoingexchangetransfusioninsouthwesternchinaduringan11yearperiodfrom2001to2011
AT qiannanzhang reportaboutterminfantswithseverehyperbilirubinemiaundergoingexchangetransfusioninsouthwesternchinaduringan11yearperiodfrom2001to2011
AT huayunhe reportaboutterminfantswithseverehyperbilirubinemiaundergoingexchangetransfusioninsouthwesternchinaduringan11yearperiodfrom2001to2011
AT xinhongchen reportaboutterminfantswithseverehyperbilirubinemiaundergoingexchangetransfusioninsouthwesternchinaduringan11yearperiodfrom2001to2011
AT ziyuhua reportaboutterminfantswithseverehyperbilirubinemiaundergoingexchangetransfusioninsouthwesternchinaduringan11yearperiodfrom2001to2011